UFPT - UFP Technologies, Inc.
NEXT EARNINGS:
May 5, 2026
EPS Est: $2.55
|
Rev Est: $154.5M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$298.00
DETAILS
HIGH:
$344.00
LOW:
$252.00
MEDIAN:
$298.00
CONSENSUS:
$298.00
UPSIDE:
23.87%
Market Cap:
1.86B
Volume:
205,881
Avg Volume:
183,551
52 Week Range:
178.26-275.51
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.10
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
4,146
IPO Date:
1993-12-17
EPS (TTM):
7.69
P/E Ratio:
25.04
Revenue (TTM):
504.42M
Total Assets:
629.00M
Total Debt:
206.03M
Cash & Equiv:
13.45M
Rev Growth (5Y):
20.5%
EPS Growth (5Y):
23.6%
FCF Growth (5Y):
17.5%
ROCE:
14.7%
Debt/Equity:
0.60
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $2.25 | $2.26 | -0.4% | $148.9M | $154.5M | -3.6% |
| 2025-11-03 | $2.39 | $2.22 | +7.7% | $154.6M | $149.1M | +3.7% |
| 2025-08-04 | $2.50 | $2.29 | +9.2% | $151.2M | $152.4M | -0.8% |
| 2025-05-06 | $2.47 | $2.05 | +20.5% | $148.1M | $145.1M | +2.1% |
| 2025-02-25 | $2.46 | $1.98 | +24.2% | $144.1M | $141.7M | +1.7% |
| 2024-11-05 | $2.11 | $1.81 | +16.6% | $145.2M | $143.1M | +1.5% |
| 2024-07-31 | $1.75 | $1.53 | +14.4% | $110.2M | $107.0M | +3.0% |
| 2024-05-01 | $1.64 | $1.10 | +49.1% | $105.0M | $97.3M | +7.9% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 504.42M | 400.07M | 353.79M | 206.32M | 179.37M | 198.38M | 190.46M | 147.84M | 146.13M | 138.85M | 139.31M | 139.22M |
| Net Income | 58.98M | 44.92M | 41.79M | 15.89M | 13.37M | 19.75M | 14.31M | 9.21M | 7.97M | 7.59M | 7.56M | 11.28M |
| EPS | 7.69 | 5.89 | 5.52 | 2.11 | 1.79 | 2.66 | 1.95 | 1.27 | 1.11 | 1.07 | 1.08 | 1.65 |
| Total Assets | 629.00M | 404.14M | 378.19M | 334.13M | 203.20M | 188.76M | 189.60M | 138.21M | 127.93M | 119.95M | 113.69M | 105.02M |
| Total Debt | 206.03M | 46.04M | 68.37M | 84.36M | 2.21M | 3.09M | 25.14M | 0 | 856,000 | 1.87M | 2.87M | 3.84M |
| Cash & Equivalents | 13.45M | 5.26M | 4.45M | 11.12M | 24.23M | 3.74M | 3.24M | 37.98M | 31.36M | 29.80M | 34.05M | 37.30M |
| Operating Cash Flow | 66.59M | 41.33M | 17.74M | 14.29M | 25.04M | 31.23M | 21.32M | 17.47M | 9.39M | 13.10M | 11.13M | 16.11M |
| Free Cash Flow | 56.94M | 30.84M | 3.96M | 8.90M | 20.67M | 25.45M | 15.89M | 7.09M | 2.10M | (3.22M) | (2.31M) | 10.28M |
| FCF per Share | 7.43 | 4.05 | 0.52 | 1.18 | 2.76 | 3.43 | 2.16 | 0.98 | 0.29 | -0.45 | -0.33 | 1.51 |
| Book Value | 342.76M | 286.09M | 237.54M | 194.45M | 176.89M | 161.99M | 140.46M | 123.71M | 113.05M | 103.57M | 94.99M | 85.59M |
| Cash & ST Investments | 13.45M | 5.26M | 4.45M | 11.12M | 24.23M | 3.74M | 3.24M | 37.98M | 31.36M | 29.80M | 34.05M | 37.30M |
| ROC Equity | 0.17 | 0.16 | 0.18 | 0.08 | 0.08 | 0.12 | 0.10 | 0.07 | 0.07 | 0.07 | 0.08 | 0.13 |